Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...

Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial ...

Hypertensive patients with stroke who develop atrial fibrillation should be critically and carefully evaluated to be placed on these NOADs for fear of hemorrhagic transformation of the ischemic ...

2024 — More than two-thirds of people taking blood thinners take direct oral anticoagulants, or DOACs, which are under- or over-prescribed in up to one in eight patients. A new study finds that most ...

Historically, recommendations for anticoagulants during pregnancy have evolved with each new publication of results concerning their use. Very early, coumarin induced embryopathies,1 especially during ...

College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, P.R. China Experimental and Research Animal Institute, Sichuan University, Chengdu 610041, P.R. China ...

Additionally, Europe follows as a significant market, with countries like Germany and the U.K. actively adopting new anticoagulant therapies within their healthcare systems. On the other hand ...

A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial, with one of the candidates also matching Bristol Myers Squibb and Pfizer ...

The properties of aptamers have enabled the development of new anticoagulant agents that block several proteins involved in the coagulation cascade. The most advanced results are obtained with ...

AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.

Striking New Moray Eel Discovered in Central Indo-Pacific River Mouths, Named After God of the Underworld Dec. 30, 2024 — A new species of black, slender moray eel has chosen the road less ...

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.